부산대학교 도서관

Strosberg JR; Moffitt Cancer Center, Tampa, FL, USA. Electronic address: jonathan.strosberg@moffitt.org.; Caplin ME; Royal Free Hospital, London, UK.; Kunz PL; Yale School of Medicine, New Haven, CT, USA.; Ruszniewski PB; Division of Gastroenterology and Pancreatology, Université de Paris and Beaujon Hospital, AP-HP, Clichy, France.; Bodei L; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Hendifar A; Cedars-Sinai Medical Center, Los Angeles, CA, USA.; Mittra E; Division of Diagnostic Radiology, Oregon Health and Science University, Portland, OR, USA.; Wolin EM; Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Yao JC; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Pavel ME; Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany.; Grande E; MD Anderson Cancer Center Madrid, Madrid, Spain.; Van Cutsem E; Division of Digestive Oncology, University of Leuven, University Hospital Gasthuisberg, Leuven, Belgium.; Seregni E; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Duarte H; Portuguese Institute of Oncology, Porto, Portugal.; Gericke G; Novartis Pharma AG, Basel, Switzerland.; Bartalotta A; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.; Mariani MF; Novartis Pharma AG, Basel, Switzerland.; Demange A; Novartis Pharma AG, Basel, Switzerland.; Mutevelic S; Novartis Pharma AG, Basel, Switzerland.; Krenning EP; Department of Nuclear Medicine, Erasmus Medical Center, Rotterdam, Netherlands.

Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

Grenader T.; Pavel M. E.; Ruszniewski P. B.; Cwikla J. B.; Phan A. T.; Raderer M.; Sedlackova E.; Cadiot G.; Wolin E. M.; Capdevila J.; Wall L.; Rindi G.; Thanh X. -M. T.; Caplin M. E.; Borbath I.; Ysebaert D.; Vitek P.; Gronbaek H.; Adenis A.; Buscail L.; Dominguez S.; Ducreux M.; Lombard-Bohas C.; Mitry E.; Ruszniewski P.; Seitz J. F.; Begum N.; Harsch I.; Pavel M.; Schofl C.; Weber M.; Wiedenmann B.; Mallath M.; Sambasivaiah K.; Saxena R.; Bajetta E.; Buonadonna A.; Buzzoni R.; Cannizzaro R.; Colao A.; de Angelis C.; Tomassetti P.; Cwikla J.; Kos-Kudla B.; Salek T.; Soler G.; Tabernero J. M.; Ahlman H.; Kjellman M.; Aithal G.; Anthoney A.; Grossman A.; Newell-Price J.; Ramage J.; Reed N.; Rees A.; Steward W.; Choti M.; CLARINET Study Group

Anticancer Drugs
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname
Grenader, T, Pavel, M E, Ruszniewski, P B, Ćwikła, J, Phan, A T, Raderer, M, Sedláčková, E, Cadiot, G, Wolin, E M, Capdevila, J, Wall, L, Rindi, G, Thanh, X M T, Caplin, M E & CLARINET Study Group 2020, 'Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumors', Anti-Cancer Drugs, vol. 31, no. 3, pp. 216-222. https://doi.org/10.1097/CAD.0000000000000909

Strosberg JR; Department of MedicineMoffitt Cancer Center, Tampa, Florida, USADivision of Cancer MedicineDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAIstituto di OncologiaPoliclinico di Monza, Monza, ItalyNovartis International AGBasel, SwitzerlandNovartis Pharmaceuticals CorporationEast Hanover, New Jersey, USASarah Cannon Research InstituteNashville, Tennessee, USAUniversity of Paris VII and Beaujon HospitalParis, FranceDigestive OncologyUniversity Hospitals Gasthuisberg, Leuven and KULeuven, Leuven, BelgiumUppsala University HospitalUppsala, SwedenDepartment of Hepatology and GastroenterologyCharité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany Jonathan.Strosberg@moffitt.org.; Yao JC; Department of MedicineMoffitt Cancer Center, Tampa, Florida, USADivision of Cancer MedicineDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAIstituto di OncologiaPoliclinico di Monza, Monza, ItalyNovartis International AGBasel, SwitzerlandNovartis Pharmaceuticals CorporationEast Hanover, New Jersey, USASarah Cannon Research InstituteNashville, Tennessee, USAUniversity of Paris VII and Beaujon HospitalParis, FranceDigestive OncologyUniversity Hospitals Gasthuisberg, Leuven and KULeuven, Leuven, BelgiumUppsala University HospitalUppsala, SwedenDepartment of Hepatology and GastroenterologyCharité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany.; Bajetta E; Department of MedicineMoffitt Cancer Center, Tampa, Florida, USADivision of Cancer MedicineDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAIstituto di OncologiaPoliclinico di Monza, Monza, ItalyNovartis International AGBasel, SwitzerlandNovartis Pharmaceuticals CorporationEast Hanover, New Jersey, USASarah Cannon Research InstituteNashville, Tennessee, USAUniversity of Paris VII and Beaujon HospitalParis, FranceDigestive OncologyUniversity Hospitals Gasthuisberg, Leuven and KULeuven, Leuven, BelgiumUppsala University HospitalUppsala, SwedenDepartment of Hepatology and GastroenterologyCharité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany.; Aout M; Department of MedicineMoffitt Cancer Center, Tampa, Florida, USADivision of Cancer MedicineDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAIstituto di OncologiaPoliclinico di Monza, Monza, ItalyNovartis International AGBasel, SwitzerlandNovartis Pharmaceuticals CorporationEast Hanover, New Jersey, USASarah Cannon Research InstituteNashville, Tennessee, USAUniversity of Paris VII and Beaujon HospitalParis, FranceDigestive OncologyUniversity Hospitals Gasthuisberg, Leuven and KULeuven, Leuven, BelgiumUppsala University HospitalUppsala, SwedenDepartment of Hepatology and GastroenterologyCharité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany.; Bakker B; Department of MedicineMoffitt Cancer Center, Tampa, Florida, USADivision of Cancer MedicineDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAIstituto di OncologiaPoliclinico di Monza, Monza, ItalyNovartis International AGBasel, SwitzerlandNovartis Pharmaceuticals CorporationEast Hanover, New Jersey, USASarah Cannon Research InstituteNashville, Tennessee, USAUniversity of Paris VII and Beaujon HospitalParis, FranceDigestive OncologyUniversity Hospitals Gasthuisberg, Leuven and KULeuven, Leuven, BelgiumUppsala University HospitalUppsala, SwedenDepartment of Hepatology and GastroenterologyCharité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany.; Hainsworth JD; Department of MedicineMoffitt Cancer Center, Tampa, Florida, USADivision of Cancer MedicineDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAIstituto di OncologiaPoliclinico di Monza, Monza, ItalyNovartis International AGBasel, SwitzerlandNovartis Pharmaceuticals CorporationEast Hanover, New Jersey, USASarah Cannon Research InstituteNashville, Tennessee, USAUniversity of Paris VII and Beaujon HospitalParis, FranceDigestive OncologyUniversity Hospitals Gasthuisberg, Leuven and KULeuven, Leuven, BelgiumUppsala University HospitalUppsala, SwedenDepartment of Hepatology and GastroenterologyCharité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany.; Ruszniewski PB; Department of MedicineMoffitt Cancer Center, Tampa, Florida, USADivision of Cancer MedicineDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAIstituto di OncologiaPoliclinico di Monza, Monza, ItalyNovartis International AGBasel, SwitzerlandNovartis Pharmaceuticals CorporationEast Hanover, New Jersey, USASarah Cannon Research InstituteNashville, Tennessee, USAUniversity of Paris VII and Beaujon HospitalParis, FranceDigestive OncologyUniversity Hospitals Gasthuisberg, Leuven and KULeuven, Leuven, BelgiumUppsala University HospitalUppsala, SwedenDepartment of Hepatology and GastroenterologyCharité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany.; Van Cutsem E; Department of MedicineMoffitt Cancer Center, Tampa, Florida, USADivision of Cancer MedicineDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAIstituto di OncologiaPoliclinico di Monza, Monza, ItalyNovartis International AGBasel, SwitzerlandNovartis Pharmaceuticals CorporationEast Hanover, New Jersey, USASarah Cannon Research InstituteNashville, Tennessee, USAUniversity of Paris VII and Beaujon HospitalParis, FranceDigestive OncologyUniversity Hospitals Gasthuisberg, Leuven and KULeuven, Leuven, BelgiumUppsala University HospitalUppsala, SwedenDepartment of Hepatology and GastroenterologyCharité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany.; Öberg K; Department of MedicineMoffitt Cancer Center, Tampa, Florida, USADivision of Cancer MedicineDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAIstituto di OncologiaPoliclinico di Monza, Monza, ItalyNovartis International AGBasel, SwitzerlandNovartis Pharmaceuticals CorporationEast Hanover, New Jersey, USASarah Cannon Research InstituteNashville, Tennessee, USAUniversity of Paris VII and Beaujon HospitalParis, FranceDigestive OncologyUniversity Hospitals Gasthuisberg, Leuven and KULeuven, Leuven, BelgiumUppsala University HospitalUppsala, SwedenDepartment of Hepatology and GastroenterologyCharité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany.; Pavel ME; Department of MedicineMoffitt Cancer Center, Tampa, Florida, USADivision of Cancer MedicineDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAIstituto di OncologiaPoliclinico di Monza, Monza, ItalyNovartis International AGBasel, SwitzerlandNovartis Pharmaceuticals CorporationEast Hanover, New Jersey, USASarah Cannon Research InstituteNashville, Tennessee, USAUniversity of Paris VII and Beaujon HospitalParis, FranceDigestive OncologyUniversity Hospitals Gasthuisberg, Leuven and KULeuven, Leuven, BelgiumUppsala University HospitalUppsala, SwedenDepartment of Hepatology and GastroenterologyCharité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany.

Publisher: BioScientifica Country of Publication: England NLM ID: 9436481 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1479-6821 (Electronic) Linking ISSN: 13510088 NLM ISO Abbreviation: Endocr Relat Cancer Subsets: MEDLINE

Bourdeleau P; Department of Pancreatology and Digestive Oncology, Beaujon Hospital (APHP.Nord), Université Paris-Cité, Clichy, France.; Couvelard A; Department of Pathology, Beaujon/Bichat Hospitals (APHP.Nord), Université Paris-Cité, Clichy/Paris, France.; Centre de Recherche sur l'Inflammation, INSERM UMR1149, FHU MOSAIC, Paris, France.; Ronot M; Department of Radiology, Beaujon Hospital (APHP.Nord), Université Paris-Cité, Clichy, France, and Centre de Recherche sur l'Inflammation, INSERM UMR1149, FHU MOSAIC, Paris, France.; Lebtahi R; Department of Nuclear Medicine, Beaujon Hospital (APHP.Nord), Université Paris-Cité, Clichy, France Centre de Recherche sur l'Inflammation, INSERM UMR1149, FHU MOSAIC, Paris, France.; Hentic O; Department of Pancreatology and Digestive Oncology, Beaujon Hospital (APHP.Nord), Université Paris-Cité, Clichy, France.; Ruszniewski P; Department of Pancreatology and Digestive Oncology, Beaujon Hospital (APHP.Nord), Université Paris-Cité, Clichy, France.; Centre de Recherche sur l'Inflammation, INSERM UMR1149, FHU MOSAIC, Paris, France.; Cros J; Department of Pathology, Beaujon/Bichat Hospitals (APHP.Nord), Université Paris-Cité, Clichy/Paris, France.; Centre de Recherche sur l'Inflammation, INSERM UMR1149, FHU MOSAIC, Paris, France.; de Mestier L; Department of Pancreatology and Digestive Oncology, Beaujon Hospital (APHP.Nord), Université Paris-Cité, Clichy, France.; Centre de Recherche sur l'Inflammation, INSERM UMR1149, FHU MOSAIC, Paris, France.

Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE

Bournet, B.; Souque, A.; Senesse, P.; Assenat, E.; Barthet, M.; Lesavre Rosenzweig, N.; Aubert, A.; O’Toole, D.; Hammel, P.; Lévy, P.; Ruszniewski, P.; Bouisson, M.; Escourrou, J.; Cordelier, P.; Buscail, L.

Gastroenterologie Clinique et Biologique. 33(3):A261-A261

Stroes ESG; From the Department of Vascular Medicine, Amsterdam University Medical Center, Amsterdam, (E.S.G.S.); Ionis Pharmaceuticals, Carlsbad (V.J.A., E.K.-P., T.A.P., S.X., S.T.), and the Divisions of Endocrinology and Metabolism (J.L.W.) and Cardiovascular Medicine (S.T.), Department of Medicine, University of California, San Diego, La Jolla - both in California; the Department of Medicine and Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada (R.A.H.); the Department of Translational and Precision Medicine, Center for Rare Disorders of Lipid Metabolism, Sapienza University of Rome, Rome (M.A.); Baylor College of Medicine and the Texas Heart Institute, Houston (C.M.B.); the National Institute for Health Research and Wellcome Trust Clinical Research Facility, Manchester University Hospital NHS Foundation Trust, Manchester, United Kingdom (H.S.); and the Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York (H.N.G.).; Alexander VJ; From the Department of Vascular Medicine, Amsterdam University Medical Center, Amsterdam, (E.S.G.S.); Ionis Pharmaceuticals, Carlsbad (V.J.A., E.K.-P., T.A.P., S.X., S.T.), and the Divisions of Endocrinology and Metabolism (J.L.W.) and Cardiovascular Medicine (S.T.), Department of Medicine, University of California, San Diego, La Jolla - both in California; the Department of Medicine and Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada (R.A.H.); the Department of Translational and Precision Medicine, Center for Rare Disorders of Lipid Metabolism, Sapienza University of Rome, Rome (M.A.); Baylor College of Medicine and the Texas Heart Institute, Houston (C.M.B.); the National Institute for Health Research and Wellcome Trust Clinical Research Facility, Manchester University Hospital NHS Foundation Trust, Manchester, United Kingdom (H.S.); and the Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York (H.N.G.).; Karwatowska-Prokopczuk E; From the Department of Vascular Medicine, Amsterdam University Medical Center, Amsterdam, (E.S.G.S.); Ionis Pharmaceuticals, Carlsbad (V.J.A., E.K.-P., T.A.P., S.X., S.T.), and the Divisions of Endocrinology and Metabolism (J.L.W.) and Cardiovascular Medicine (S.T.), Department of Medicine, University of California, San Diego, La Jolla - both in California; the Department of Medicine and Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada (R.A.H.); the Department of Translational and Precision Medicine, Center for Rare Disorders of Lipid Metabolism, Sapienza University of Rome, Rome (M.A.); Baylor College of Medicine and the Texas Heart Institute, Houston (C.M.B.); the National Institute for Health Research and Wellcome Trust Clinical Research Facility, Manchester University Hospital NHS Foundation Trust, Manchester, United Kingdom (H.S.); and the Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York (H.N.G.).; Hegele RA; From the Department of Vascular Medicine, Amsterdam University Medical Center, Amsterdam, (E.S.G.S.); Ionis Pharmaceuticals, Carlsbad (V.J.A., E.K.-P., T.A.P., S.X., S.T.), and the Divisions of Endocrinology and Metabolism (J.L.W.) and Cardiovascular Medicine (S.T.), Department of Medicine, University of California, San Diego, La Jolla - both in California; the Department of Medicine and Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada (R.A.H.); the Department of Translational and Precision Medicine, Center for Rare Disorders of Lipid Metabolism, Sapienza University of Rome, Rome (M.A.); Baylor College of Medicine and the Texas Heart Institute, Houston (C.M.B.); the National Institute for Health Research and Wellcome Trust Clinical Research Facility, Manchester University Hospital NHS Foundation Trust, Manchester, United Kingdom (H.S.); and the Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York (H.N.G.).; Arca M; From the Department of Vascular Medicine, Amsterdam University Medical Center, Amsterdam, (E.S.G.S.); Ionis Pharmaceuticals, Carlsbad (V.J.A., E.K.-P., T.A.P., S.X., S.T.), and the Divisions of Endocrinology and Metabolism (J.L.W.) and Cardiovascular Medicine (S.T.), Department of Medicine, University of California, San Diego, La Jolla - both in California; the Department of Medicine and Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada (R.A.H.); the Department of Translational and Precision Medicine, Center for Rare Disorders of Lipid Metabolism, Sapienza University of Rome, Rome (M.A.); Baylor College of Medicine and the Texas Heart Institute, Houston (C.M.B.); the National Institute for Health Research and Wellcome Trust Clinical Research Facility, Manchester University Hospital NHS Foundation Trust, Manchester, United Kingdom (H.S.); and the Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York (H.N.G.).; Ballantyne CM; From the Department of Vascular Medicine, Amsterdam University Medical Center, Amsterdam, (E.S.G.S.); Ionis Pharmaceuticals, Carlsbad (V.J.A., E.K.-P., T.A.P., S.X., S.T.), and the Divisions of Endocrinology and Metabolism (J.L.W.) and Cardiovascular Medicine (S.T.), Department of Medicine, University of California, San Diego, La Jolla - both in California; the Department of Medicine and Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada (R.A.H.); the Department of Translational and Precision Medicine, Center for Rare Disorders of Lipid Metabolism, Sapienza University of Rome, Rome (M.A.); Baylor College of Medicine and the Texas Heart Institute, Houston (C.M.B.); the National Institute for Health Research and Wellcome Trust Clinical Research Facility, Manchester University Hospital NHS Foundation Trust, Manchester, United Kingdom (H.S.); and the Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York (H.N.G.).; Soran H; From the Department of Vascular Medicine, Amsterdam University Medical Center, Amsterdam, (E.S.G.S.); Ionis Pharmaceuticals, Carlsbad (V.J.A., E.K.-P., T.A.P., S.X., S.T.), and the Divisions of Endocrinology and Metabolism (J.L.W.) and Cardiovascular Medicine (S.T.), Department of Medicine, University of California, San Diego, La Jolla - both in California; the Department of Medicine and Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada (R.A.H.); the Department of Translational and Precision Medicine, Center for Rare Disorders of Lipid Metabolism, Sapienza University of Rome, Rome (M.A.); Baylor College of Medicine and the Texas Heart Institute, Houston (C.M.B.); the National Institute for Health Research and Wellcome Trust Clinical Research Facility, Manchester University Hospital NHS Foundation Trust, Manchester, United Kingdom (H.S.); and the Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York (H.N.G.).; Prohaska TA; From the Department of Vascular Medicine, Amsterdam University Medical Center, Amsterdam, (E.S.G.S.); Ionis Pharmaceuticals, Carlsbad (V.J.A., E.K.-P., T.A.P., S.X., S.T.), and the Divisions of Endocrinology and Metabolism (J.L.W.) and Cardiovascular Medicine (S.T.), Department of Medicine, University of California, San Diego, La Jolla - both in California; the Department of Medicine and Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada (R.A.H.); the Department of Translational and Precision Medicine, Center for Rare Disorders of Lipid Metabolism, Sapienza University of Rome, Rome (M.A.); Baylor College of Medicine and the Texas Heart Institute, Houston (C.M.B.); the National Institute for Health Research and Wellcome Trust Clinical Research Facility, Manchester University Hospital NHS Foundation Trust, Manchester, United Kingdom (H.S.); and the Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York (H.N.G.).; Xia S; From the Department of Vascular Medicine, Amsterdam University Medical Center, Amsterdam, (E.S.G.S.); Ionis Pharmaceuticals, Carlsbad (V.J.A., E.K.-P., T.A.P., S.X., S.T.), and the Divisions of Endocrinology and Metabolism (J.L.W.) and Cardiovascular Medicine (S.T.), Department of Medicine, University of California, San Diego, La Jolla - both in California; the Department of Medicine and Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada (R.A.H.); the Department of Translational and Precision Medicine, Center for Rare Disorders of Lipid Metabolism, Sapienza University of Rome, Rome (M.A.); Baylor College of Medicine and the Texas Heart Institute, Houston (C.M.B.); the National Institute for Health Research and Wellcome Trust Clinical Research Facility, Manchester University Hospital NHS Foundation Trust, Manchester, United Kingdom (H.S.); and the Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York (H.N.G.).; Ginsberg HN; From the Department of Vascular Medicine, Amsterdam University Medical Center, Amsterdam, (E.S.G.S.); Ionis Pharmaceuticals, Carlsbad (V.J.A., E.K.-P., T.A.P., S.X., S.T.), and the Divisions of Endocrinology and Metabolism (J.L.W.) and Cardiovascular Medicine (S.T.), Department of Medicine, University of California, San Diego, La Jolla - both in California; the Department of Medicine and Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada (R.A.H.); the Department of Translational and Precision Medicine, Center for Rare Disorders of Lipid Metabolism, Sapienza University of Rome, Rome (M.A.); Baylor College of Medicine and the Texas Heart Institute, Houston (C.M.B.); the National Institute for Health Research and Wellcome Trust Clinical Research Facility, Manchester University Hospital NHS Foundation Trust, Manchester, United Kingdom (H.S.); and the Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York (H.N.G.).; Witztum JL; From the Department of Vascular Medicine, Amsterdam University Medical Center, Amsterdam, (E.S.G.S.); Ionis Pharmaceuticals, Carlsbad (V.J.A., E.K.-P., T.A.P., S.X., S.T.), and the Divisions of Endocrinology and Metabolism (J.L.W.) and Cardiovascular Medicine (S.T.), Department of Medicine, University of California, San Diego, La Jolla - both in California; the Department of Medicine and Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada (R.A.H.); the Department of Translational and Precision Medicine, Center for Rare Disorders of Lipid Metabolism, Sapienza University of Rome, Rome (M.A.); Baylor College of Medicine and the Texas Heart Institute, Houston (C.M.B.); the National Institute for Health Research and Wellcome Trust Clinical Research Facility, Manchester University Hospital NHS Foundation Trust, Manchester, United Kingdom (H.S.); and the Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York (H.N.G.).; Tsimikas S; From the Department of Vascular Medicine, Amsterdam University Medical Center, Amsterdam, (E.S.G.S.); Ionis Pharmaceuticals, Carlsbad (V.J.A., E.K.-P., T.A.P., S.X., S.T.), and the Divisions of Endocrinology and Metabolism (J.L.W.) and Cardiovascular Medicine (S.T.), Department of Medicine, University of California, San Diego, La Jolla - both in California; the Department of Medicine and Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada (R.A.H.); the Department of Translational and Precision Medicine, Center for Rare Disorders of Lipid Metabolism, Sapienza University of Rome, Rome (M.A.); Baylor College of Medicine and the Texas Heart Institute, Houston (C.M.B.); the National Institute for Health Research and Wellcome Trust Clinical Research Facility, Manchester University Hospital NHS Foundation Trust, Manchester, United Kingdom (H.S.); and the Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York (H.N.G.).

Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE